UGT1A1 and neutropenia: However, as a substantial proportion of UGT1A1*28 homozygous patients do not experience grade ≥ 3 neutropenia, the management of neutropenia is considered more appropriate than prophylactic screening for patients with the UGT1A1 genotype [103, 105].